148 related articles for article (PubMed ID: 38326471)
1. SLC15A4 inhibitor blocks inflammation.
Crunkhorn S
Nat Rev Drug Discov; 2024 Mar; 23(3):174. PubMed ID: 38326471
[No Abstract] [Full Text] [Related]
2. Human SLC15A4 is crucial for TLR-mediated type I interferon production and mitochondrial integrity.
Kobayashi T; Nguyen-Tien D; Ohshima D; Karyu H; Shimabukuro-Demoto S; Yoshida-Sugitani R; Toyama-Sorimachi N
Int Immunol; 2021 Jun; 33(7):399-406. PubMed ID: 33560415
[TBL] [Abstract][Full Text] [Related]
3. SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress.
Kobayashi T; Nguyen-Tien D; Sorimachi Y; Sugiura Y; Suzuki T; Karyu H; Shimabukuro-Demoto S; Uemura T; Okamura T; Taguchi T; Ueki K; Kato N; Goda N; Dohmae N; Takubo K; Suematsu M; Toyama-Sorimachi N
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385317
[TBL] [Abstract][Full Text] [Related]
4. SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL.
Zhang H; Bernaleau L; Delacrétaz M; Hasanovic E; Drobek A; Eibel H; Rebsamen M
Cell Rep; 2023 Aug; 42(8):112916. PubMed ID: 37527038
[TBL] [Abstract][Full Text] [Related]
5. Identification of
Mazzei A; Serino G; Romano A; Piccinno E; Scalavino V; Valentini AM; Armentano R; Schiavone R; Giannelli G; Verri T; Barca A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361959
[TBL] [Abstract][Full Text] [Related]
6. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.
Heinz LX; Lee J; Kapoor U; Kartnig F; Sedlyarov V; Papakostas K; César-Razquin A; Essletzbichler P; Goldmann U; Stefanovic A; Bigenzahn JW; Scorzoni S; Pizzagalli MD; Bensimon A; Müller AC; King FJ; Li J; Girardi E; Mbow ML; Whitehurst CE; Rebsamen M; Superti-Furga G
Nature; 2020 May; 581(7808):316-322. PubMed ID: 32433612
[TBL] [Abstract][Full Text] [Related]
7. The phagosomal solute transporter SLC15A4 promotes inflammasome activity via mTORC1 signaling and autophagy restraint in dendritic cells.
López-Haber C; Netting DJ; Hutchins Z; Ma X; Hamilton KE; Mantegazza AR
EMBO J; 2022 Oct; 41(20):e111161. PubMed ID: 36031853
[TBL] [Abstract][Full Text] [Related]
8. A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity.
Boeszoermenyi A; Bernaleau L; Chen X; Kartnig F; Xie M; Zhang H; Zhang S; Delacrétaz M; Koren A; Hopp AK; Dvorak V; Kubicek S; Aletaha D; Yang M; Rebsamen M; Heinz LX; Superti-Furga G
Nat Commun; 2023 Oct; 14(1):6626. PubMed ID: 37863876
[TBL] [Abstract][Full Text] [Related]
9. Association Study Between SLC15A4 Polymorphisms and Haplotypes and Systemic Lupus Erythematosus in a Han Chinese Population.
Zhang M; Chen F; Zhang D; Zhai Z; Hao F
Genet Test Mol Biomarkers; 2016 Aug; 20(8):451-8. PubMed ID: 27362648
[TBL] [Abstract][Full Text] [Related]
10. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling.
Chen X; Xie M; Zhang S; Monguió-Tortajada M; Yin J; Liu C; Zhang Y; Delacrétaz M; Song M; Wang Y; Dong L; Ding Q; Zhou B; Tian X; Deng H; Xu L; Liu X; Yang Z; Chang Q; Na J; Zeng W; Superti-Furga G; Rebsamen M; Yang M
Nat Commun; 2023 Oct; 14(1):6627. PubMed ID: 37863913
[TBL] [Abstract][Full Text] [Related]
12. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production.
Kobayashi T; Shimabukuro-Demoto S; Yoshida-Sugitani R; Furuyama-Tanaka K; Karyu H; Sugiura Y; Shimizu Y; Hosaka T; Goto M; Kato N; Okamura T; Suematsu M; Yokoyama S; Toyama-Sorimachi N
Immunity; 2014 Sep; 41(3):375-388. PubMed ID: 25238095
[TBL] [Abstract][Full Text] [Related]
13. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.
Blasius AL; Arnold CN; Georgel P; Rutschmann S; Xia Y; Lin P; Ross C; Li X; Smart NG; Beutler B
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19973-8. PubMed ID: 21045126
[TBL] [Abstract][Full Text] [Related]
14. Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency.
Simm F; Griesbeck A; Choukair D; Weiß B; Paramasivam N; Klammt J; Schlesner M; Wiemann S; Martinez C; Hoffmann GF; Pfäffle RW; Bettendorf M; Rappold GA
Genet Med; 2018 Jul; 20(7):728-736. PubMed ID: 29261175
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer.
Skopelitou D; Srivastava A; Miao B; Kumar A; Dymerska D; Paramasivam N; Schlesner M; Lubinski J; Hemminki K; Försti A; Reddy Bandapalli O
Mol Genet Genomics; 2022 Jul; 297(4):965-979. PubMed ID: 35562597
[TBL] [Abstract][Full Text] [Related]
16. Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.
Zuo XB; Sheng YJ; Hu SJ; Gao JP; Li Y; Tang HY; Tang XF; Cheng H; Yin XY; Wen LL; Sun LD; Yang S; Cui Y; Zhang XJ
Rheumatol Int; 2014 Apr; 34(4):459-64. PubMed ID: 24091983
[TBL] [Abstract][Full Text] [Related]
17. Lysosome biogenesis regulated by the amino-acid transporter SLC15A4 is critical for functional integrity of mast cells.
Kobayashi T; Tsutsui H; Shimabukuro-Demoto S; Yoshida-Sugitani R; Karyu H; Furuyama-Tanaka K; Ohshima D; Kato N; Okamura T; Toyama-Sorimachi N
Int Immunol; 2017 Dec; 29(12):551-566. PubMed ID: 29155995
[TBL] [Abstract][Full Text] [Related]
18. The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid-sensing TLRs and ligands to endolysosomes.
Rimann I; Gonzalez-Quintial R; Baccala R; Kiosses WB; Teijaro JR; Parker CG; Li X; Beutler B; Kono DH; Theofilopoulos AN
Proc Natl Acad Sci U S A; 2022 Apr; 119(14):e2200544119. PubMed ID: 35349343
[TBL] [Abstract][Full Text] [Related]
19. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling.
Nakamura N; Lill JR; Phung Q; Jiang Z; Bakalarski C; de Mazière A; Klumperman J; Schlatter M; Delamarre L; Mellman I
Nature; 2014 May; 509(7499):240-4. PubMed ID: 24695226
[TBL] [Abstract][Full Text] [Related]
20. Neuron-derived orphan receptor 1: working towards a common goal.
Ma Y
J Mol Cell Cardiol; 2015 Mar; 80():98-100. PubMed ID: 25575883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
